Skip to main content
Biogen Inc. (LON:0R1B)
London flag London · Delayed Price · Currency is GBP · Price in USD
135.73
-0.59 (-0.43%)
At close: Feb 19, 2025

Biogen Revenue

In the year 2024, Biogen had annual revenue of $9.68B USD, down -1.62%. Biogen had revenue of $2.45B in the quarter ending December 31, 2024, with 2.87% growth.

Revenue
$9.68B
Revenue Growth
-1.62%
P/S Ratio
n/a
Revenue / Employee
$1.27M
Employees
7,605
Market Cap
16.28B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Genus 668.80M
Revenue Rankings

Biogen News

More News